(VIANEWS) - Opiant Pharmaceuticals (OPNT), iRadimed Corporation (IRMD), Zoom (ZM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Opiant Pharmaceuticals (OPNT)
56.6% sales growth and 4.05% return on equity
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.
Opiant Pharmaceuticals's sales growth this year is anticipated to be 59.4% and a negative 41.3% for next year.
Year-on-year quarterly revenue growth grew by 79.4%, now sitting on 43.91M for the twelve trailing months.
Volume
Today's last reported volume for Opiant Pharmaceuticals is 98931 which is 48.08% above its average volume of 66808.
Opiant Pharmaceuticals's sales growth for the next quarter is 56.6%. The company's growth estimates for the current quarter and the next is 93.8% and 69.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.05%.
Volatility
Opiant Pharmaceuticals's last day, last week, and last month's current intraday variation average was 7.65%, 5.47%, and 4.52%, respectively.
Opiant Pharmaceuticals's highest amplitude of average volatility was 10.12% (day), 8.60% (last week), and 8.65% (last month), respectively.
Opiant Pharmaceuticals's Stock Yearly Top and Bottom Value
Opiant Pharmaceuticals's stock is valued at $24.69 at 15:22 EST, way under its 52-week high of $37.71 and way above its 52-week low of $10.00.
Opiant Pharmaceuticals's Moving Average
Opiant Pharmaceuticals's worth is way under its 50-day moving average of $28.79 and above its 200-day moving average of $22.55.2. iRadimed Corporation (IRMD)
20% sales growth and 13.97% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
iRadimed Corporation's sales growth this year is expected to be 31.1% and 9.7% for next year.
Year-on-year quarterly revenue growth grew by 38.9%, now sitting on 41.81M for the twelve trailing months.
Volume
Today's last reported volume for iRadimed Corporation is 201432 which is 159% above its average volume of 77771.
iRadimed Corporation's sales growth for the next quarter is 20%. The company's growth estimates for the current quarter and the next is 200% and 115.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.97%.
Volatility
iRadimed Corporation's last day, last week, and last month's current intraday variation average was 6.24%, 2.63%, and 4.03%, respectively.
iRadimed Corporation's highest amplitude of average volatility was 7.95% (day), 5.54% (last week), and 6.15% (last month), respectively.
iRadimed Corporation's Stock Yearly Top and Bottom Value
iRadimed Corporation's stock is valued at $49.70 at 15:22 EST, under its 52-week high of $54.73 and way above its 52-week low of $21.65.
iRadimed Corporation's Moving Average
iRadimed Corporation's value is way above its 50-day moving average of $44.89 and way higher than its 200-day moving average of $37.14.3. Zoom (ZM)
15.3% sales growth and 34.64% return on equity
Zoom Video Communications, Inc. provides a video-first communications platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
Zoom's sales growth this year is anticipated to be 51.5% and 18% for next year.
Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 3.91B for the twelve trailing months.
Volume
Today's last reported volume for Zoom is 4376690 which is 2.11% below its average volume of 4471060.
Zoom's sales growth is a negative 0% for the current quarter and 15.3% for the next. The company's growth estimates for the ongoing quarter and the next is 10.1% and negative -13.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.64%.
Volatility
Zoom's last day, last week, and last month's current intraday variation average was 0.98%, 3.43%, and 3.88%, respectively.
Zoom's highest amplitude of average volatility was 6.98% (day), 7.45% (last week), and 8.01% (last month), respectively.
Zoom's Stock Yearly Top and Bottom Value
Zoom's stock is valued at $110.42 at 15:22 EST, way below its 52-week low of $175.27.
Zoom's Moving Average
Zoom's worth is way below its 50-day moving average of $246.95 and way under its 200-day moving average of $312.18.Previous days news about Zoom(ZM)
- According to The New York Times on Friday, 4 March, "McKinsey recently hosted a "thank-a-thon." O.C. Tanner, a software company, invites workers' family members to Zoom meetings celebrating their achievements. "
- According to Bloomberg Quint on Thursday, 3 March, "In the world of the ultra-rich, phones are lighting up and Zoom calls are being initiated about possibly purchasing assets at risk from sanctions at potentially bargain levels. "
- According to Bloomberg Quint on Friday, 4 March, "Apple Inc. has set an April 11 deadline for corporate employees to return to in-person work, marking a key test of whether the tech giant can reestablish office life in the Zoom era."
4. Teradyne (TER)
12.3% sales growth and 44.97% return on equity
Teradyne, Inc. designs, develops, manufactures, sells, and supports automatic test equipment worldwide.
Teradyne's sales growth this year is anticipated to be 16.8% and 6.1% for next year.
Year-on-year quarterly revenue growth grew by 29.5%, now sitting on 3.45B for the twelve trailing months.
Volume
Today's last reported volume for Teradyne is 1074180 which is 46.44% below its average volume of 2005900.
Teradyne's sales growth is a negative 0% for the ongoing quarter and 12.3% for the next. The company's growth estimates for the current quarter and the next is 21.2% and 7.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.97%.
Volatility
Teradyne's last day, last week, and last month's current intraday variation average was 5.01%, 3.42%, and 2.67%, respectively.
Teradyne's highest amplitude of average volatility was 7.09% (day), 5.06% (last week), and 4.78% (last month), respectively.
Teradyne's Stock Yearly Top and Bottom Value
Teradyne's stock is valued at $109.40 at 15:22 EST, way under its 52-week high of $161.54 and above its 52-week low of $104.05.
Teradyne's Moving Average
Teradyne's worth is way below its 50-day moving average of $135.78 and way below its 200-day moving average of $126.54.5. Hope Bancorp (HOPE)
7% sales growth and 9.87% return on equity
Hope Bancorp, Inc. operates as the bank holding company for Bank of Hope that provides banking services for small and medium-sized businesses, and individuals in the United States.
Hope Bancorp's sales growth this year is expected to be 7.5% and 9% for next year.
Year-on-year quarterly revenue growth grew by 38.4%, now sitting on 568.56M for the twelve trailing months.
Volume
Today's last reported volume for Hope Bancorp is 720217 which is 15.48% below its average volume of 852156.
Hope Bancorp's sales growth for the next quarter is 7%. The company's growth estimates for the current quarter and the next is 11.4% and negative -4.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.87%.
Volatility
Hope Bancorp's last day, last week, and last month's current intraday variation average was 3.61%, 2.79%, and 1.59%, respectively.
Hope Bancorp's highest amplitude of average volatility was 2.57% (day), 3.60% (last week), and 2.65% (last month), respectively.
Hope Bancorp's Stock Yearly Top and Bottom Value
Hope Bancorp's stock is valued at $16.07 at 15:22 EST, under its 52-week high of $17.68 and way above its 52-week low of $12.48.
Hope Bancorp's Moving Average
Hope Bancorp's worth is under its 50-day moving average of $16.23 and above its 200-day moving average of $14.81.6. Discover Financial Services (DFS)
5.4% sales growth and 44.06% return on equity
Discover Financial Services, through its subsidiaries, operates as a direct banking and payment services company in the United States.
Discover Financial Services's sales growth this year is anticipated to be 8.9% and 0.7% for next year.
Year-on-year quarterly revenue growth grew by 32%, now sitting on 11.49B for the twelve trailing months.
Volume
Today's last reported volume for Discover Financial Services is 1728770 which is 4.66% below its average volume of 1813380.
Discover Financial Services's sales growth for the next quarter is 5.4%. The company's growth estimates for the ongoing quarter and the next is 32.7% and 13.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.06%.
Volatility
Discover Financial Services's last day, last week, and last month's current intraday variation average was 8.75%, 5.35%, and 3.30%, respectively.
Discover Financial Services's highest amplitude of average volatility was 7.84% (day), 5.48% (last week), and 4.47% (last month), respectively.
Discover Financial Services's Stock Yearly Top and Bottom Value
Discover Financial Services's stock is valued at $104.83 at 15:22 EST, way under its 52-week high of $135.69 and way above its 52-week low of $81.27.